Targeted Biologic Therapies
PARP Inhibitors And Breast Cancer Treatment
PARP Inhibitors are a new class of targeted drug therapy that may block Poly (ADP-Ribose) Polymerase, a protein that repairs cancer cells after they are damaged by treatment. Learn how PARP Inhibitors may be used to treat breast cancer.
What Is Targeted Therapy for Breast Cancer Treatment?
Targeted therapies for breast cancer treatment are aimed at specific processes of cancer cell growth, division and lifecycle. These drugs focus on proteins that signal cancer cells to grow and divide uncontrollably. Targeted therapies do their work on specific cancer cells, and are less likely than chemotherapy to affect healthy tissues. Learn more about this for of breast cancer treatment.
Avastin – Bevacizumab – Targeted Biologic Therapy - Description, Side Effects
Avastin (bevacizumab) is a synthetic antibody that is used in combination with chemotherapy to treat metastatic breast cancer. It is an anti-angiogenesis drug, that prevents the formation of new blood vessels to the tumor. Read more about Avastin, how it works, and side effects
Tykerb –Lapatinib - A Targeted Biologic Therapy for Metastatic Breast Cancer
Tykerb (lapatinib) is a targeted biologic therapy given as treatment for HER2 positive metastatic breast cancer. Tykerb can be taken with Xeloda, another oral chemotherapy drug, to extend survival and prevent the progression of advanced breast cancer. Read about how Tykerb works, possible side effects and drug interactions.
Herceptin as a Targeted Breast Cancer Treatment
This is a description of Herceptin, how it works to treat HER2 breast cancer, its side effects, and self-care tips.
Iressa (Gefitinib) – Targeted Therapy Drug
Iressa is being studied in combination with Arimidex, for treatment of metastatic breast cancer. It is in tablet form, taken daily.